{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:18:07Z","timestamp":1779110287774,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018617","name":"Liaoning Revitalization Talents Program","doi-asserted-by":"publisher","award":["XLYC1907103"],"award-info":[{"award-number":["XLYC1907103"]}],"id":[{"id":"10.13039\/501100018617","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bcp.2026.117777","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T15:59:44Z","timestamp":1770307184000},"page":"117777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Icaritin enhances the antitumor efficacy of irinotecan by dual-targeting carboxylesterase 2 and p53 in vitro and in vivo"],"prefix":"10.1016","volume":"247","author":[{"given":"Jiahui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlai","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zujia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5046-9996","authenticated-orcid":false,"given":"Jingjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongshun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bcp.2026.117777_b0005","first-page":"2012","article-title":"Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans, Clinical cancer research : an official journal of the American Association for","volume":"6","author":"Santos","year":"2000","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.117777_b0010","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0090-9556(24)15060-X","article-title":"3rd, Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following I.V. infusion of [(14)C]CPT-11 in cancer patients","volume":"28","author":"Slatter","year":"2000","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.bcp.2026.117777_b0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bcp.2010.09.001","article-title":"Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11","volume":"81","author":"Hatfield","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"17","key":"10.1016\/j.bcp.2026.117777_b0020","first-page":"4725","article-title":"Proficient metabolism of irinotecan by a human intestinal carboxylesterase","volume":"60","author":"Khanna","year":"2000","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bcp.2026.117777_b0025","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0006-2952(96)00457-1","article-title":"Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase","volume":"52","author":"Rivory","year":"1996","journal-title":"Biochem. Pharmacol."},{"issue":"3a","key":"10.1016\/j.bcp.2026.117777_b0030","first-page":"2067","article-title":"In vitro activation of irinotecan to SN-38 by human liver and intestine","volume":"19","author":"Ahmed","year":"1999","journal-title":"Anticancer Res"},{"issue":"8","key":"10.1016\/j.bcp.2026.117777_b0035","first-page":"2696","article-title":"Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells, Clinical cancer research : an official journal of the American Association for","volume":"8","author":"Wu","year":"2002","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bcp.2026.117777_b0040","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1158\/1078-0432.CCR-12-1184","article-title":"Human carboxylesterase-2 hydrolyzes the prodrug of gemcitabine (LY2334737) and confers prodrug sensitivity to cancer cells","volume":"19","author":"Pratt","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.117777_b0045","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/molecules13020412","article-title":"Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs","volume":"13","author":"Hosokawa","year":"2008","journal-title":"Molecules (basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.bcp.2026.117777_b0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/bbrc.1997.6413","article-title":"Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver","volume":"233","author":"Schwer","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2026.117777_b0055","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.apsb.2018.05.005","article-title":"Human carboxylesterases: a comprehensive review","volume":"8","author":"Wang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2026.117777_b0060","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5280736","article-title":"The Relationship between TP53 Gene Status and Carboxylesterase 2 Expression in Human Colorectal Cancer","volume":"2018","author":"Ishimine","year":"2018","journal-title":"Dis. Markers"},{"issue":"2","key":"10.1016\/j.bcp.2026.117777_b0065","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/07357900701560786","article-title":"Carboxylesterase 2 is downregulated in colorectal cancer following progression of the disease","volume":"26","author":"Tang","year":"2008","journal-title":"Cancer Invest."},{"issue":"12","key":"10.1016\/j.bcp.2026.117777_b0070","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1124\/dmd.110.034454","article-title":"In vitro evaluation of inhibitory effects of antidiabetic and antihyperlipidemic drugs on human carboxylesterase activities","volume":"38","author":"Fukami","year":"2010","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.bcp.2026.117777_b0075","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2133\/dmpk.DMPK-12-RG-143","article-title":"Evaluation of the inhibitory effects of antihypertensive drugs on human carboxylesterase in vitro","volume":"28","author":"Yanjiao","year":"2013","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.bcp.2026.117777_b0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.fitote.2015.01.004","article-title":"Fructus Psoraleae contains natural compounds with potent inhibitory effects towards human carboxylesterase 2","volume":"101","author":"Li","year":"2015","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bcp.2026.117777_b0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.fitote.2016.09.022","article-title":"Identification and characterization of naturally occurring inhibitors against human carboxylesterase 2 in White Mulberry Root-bark","volume":"115","author":"Liu","year":"2016","journal-title":"Fitoterapia"},{"issue":"2","key":"10.1016\/j.bcp.2026.117777_b0090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4014\/jmb.2306.06020","article-title":"Ganodermanontriol Suppresses the Progression of Lung Adenocarcinoma by Activating CES2 to Enhance the Metabolism of Mycophenolate Mofetil","volume":"34","author":"Xie","year":"2024","journal-title":"J. Microbiol. Biotechnol."},{"issue":"6","key":"10.1016\/j.bcp.2026.117777_b0095","doi-asserted-by":"crossref","first-page":"431","DOI":"10.7555\/JBR.37.20230047","article-title":"Cisplatin increases carboxylesterases through increasing PXR mediated by the decrease of DEC1","volume":"37","author":"Xu","year":"2023","journal-title":"J. Biomed. Res."},{"issue":"7","key":"10.1016\/j.bcp.2026.117777_b0100","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.3390\/molecules23071656","article-title":"Comparison of the active compositions between raw and processed Epimedium from different species","volume":"23","author":"Zhang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2026.117777_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1023779","article-title":"Epimedii Herba: an ancient chinese herbal medicine in the prevention and treatment of rheumatoid arthritis","volume":"10","author":"Zhang","year":"2022","journal-title":"Front. Chem."},{"issue":"51","key":"10.1016\/j.bcp.2026.117777_b0110","doi-asserted-by":"crossref","first-page":"28474","DOI":"10.1021\/acsami.5b09573","article-title":"A Two-Photon Ratiometric Fluorescent Probe for Imaging Carboxylesterase 2 in living Cells and Tissues","volume":"7","author":"Jin","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bcp.2026.117777_b0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.toxlet.2018.06.1220","article-title":"JBP485 attenuates vancomycin-induced nephrotoxicity by regulating the expressions of organic anion transporter (Oat) 1, Oat3, organic cation transporter 2 (Oct2), multidrug resistance-associated protein 2 (Mrp2) and P-glycoprotein (P-gp) in rats","volume":"295","author":"Shijie","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.bcp.2026.117777_b0190","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bcp.2012.04.002","article-title":"Age-related inducibility of carboxylesterases by the antiepileptic agent phenobarbital and implications in drug metabolism and lipid accumulation","volume":"84","author":"Xiao","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117777_b0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s10020-024-00864-1","article-title":"\u03b2-hydroxybutyrate resensitizes colorectal cancer cells to oxaliplatin by suppressing H3K79 methylation in vitro and in vivo","volume":"30","author":"Deng","year":"2024","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.117777_b0125","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13020-024-00967-1","article-title":"An optimal combination of four active components in Huangqin decoction for the synergistic sensitization of irinotecan against colorectal cancer","volume":"19","author":"Zhou","year":"2024","journal-title":"Chin. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.117777_b0130","article-title":"The relationship between TP53 gene status and carboxylesterase 2 expression in human colorectal cancer","volume":"2018","author":"Ishimine","year":"2018","journal-title":"Dis. Markers"},{"issue":"16","key":"10.1016\/j.bcp.2026.117777_b0135","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1055\/s-0030-1250042","article-title":"Icaritin induces apoptosis of HepG2 cells via the JNK1 signaling pathway independent of the estrogen receptor","volume":"76","author":"He","year":"2010","journal-title":"Planta Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.117777_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016781","article-title":"Icaritin causes sustained ERK1\/2 activation and induces apoptosis in human endometrial cancer cells","volume":"6","author":"Tong","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.117777_b0145","article-title":"Icaritin: a phytomolecule with enormous pharmacological values","volume":"113772","author":"Huong","year":"2023","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bcp.2026.117777_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.959902","article-title":"The role of pregnane X receptor (PXR) in substance metabolism","volume":"13","author":"Lv","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117777_b0155","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1517\/17425250903483215","article-title":"Nuclear receptor-mediated regulation of carboxylesterase expression and activity","volume":"6","author":"Staudinger","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.117777_b0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lfs.2014.07.019","article-title":"Glucose dominates the regulation of carboxylesterases induced by lipopolysaccharide or interleukin-6 in primary mouse hepatocytes","volume":"112","author":"Xiong","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2026.117777_b0165","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejps.2017.02.031","article-title":"Involvement of pregnane X receptor in the suppression of carboxylesterases by metformin in vivo and in vitro, mediated by the activation of AMPK and JNK signaling pathway","volume":"102","author":"Shan","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bcp.2026.117777_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110926","article-title":"Icaritin activates p53 and inhibits aerobic glycolysis in liver cancer cells","volume":"392","author":"Zhou","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2026.117777_b0175","doi-asserted-by":"crossref","unstructured":"D. Xiao, D. Yang, L. Guo, W. Lu, M. Charpentier, B. Yan, Regulation of carboxylesterase-2 expression by p53 family proteins and enhanced anti-cancer activities among 5-fluorouracil, irinotecan and doxazolidine prodrug, (2013).","DOI":"10.1111\/bph.12125"},{"issue":"11","key":"10.1016\/j.bcp.2026.117777_b0180","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/2211-5463.12985","article-title":"Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells","volume":"10","author":"Han","year":"2020","journal-title":"FEBS Open Bio"},{"issue":"1","key":"10.1016\/j.bcp.2026.117777_b0185","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.124.001916","article-title":"Impact of genetic polymorphisms and drug-drug interactions mediated by carboxylesterase 1 on remimazolam deactivation","volume":"53","author":"Wang","year":"2025","journal-title":"Drug Metab. Dispos."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:04:28Z","timestamp":1779109468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226001085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":38,"alternative-id":["S0006295226001085"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117777","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Icaritin enhances the antitumor efficacy of irinotecan by dual-targeting carboxylesterase 2 and p53 in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117777","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117777"}}